Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy.
about
Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.Developing a Brief Scale to Measure HIV Transmission Risk Among Injecting Drug Users.A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study.HIV and the criminalisation of drug use among people who inject drugs: a systematic review.Syringe Sharing Among a Prospective Cohort of Street-Involved Youth: Implications for Needle Distribution Programs.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
P2860
Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@en
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@nl
type
label
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@en
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@nl
prefLabel
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@en
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@nl
P2093
P2860
P1433
P1476
Change in HIV-HCV risk-taking ...... iod and harm reduction policy.
@en
P2093
Cécile Denis
Jacques Dubernet
Jean-Pierre Daulouède
Melina Fatseas
P2860
P2888
P304
P356
10.1007/S10461-011-0054-4
P577
2012-10-01T00:00:00Z